Genentech, Inc. 401(k) Review & Grade
U.S. Roche 401(k) Savings Plan
South San Francisco, CAManufacturing22,302 active participantsPlan year 2024
Estimate from the plan's Form 5500 filing · How we grade
$17,667Employer $ per active participant
$18,871Employee $ saved per active participant
0.01%Direct admin cost, % of plan assets
$14.3BNet plan assets, end of year
$396,176Average balance per account
Score breakdown
- Employer generosity49.0 / 5098th percentile for employer $ per participant
- Low cost24.0 / 2596th percentile for low admin cost vs. same-size plans
- Employee saving14.1 / 1594th percentile for employee $ per participant
- Plan features0 / 10No auto-enrollment or default investment reported
Total score87 / 100 · Grade A
This plan vs. peers
Peers: Manufacturing plans with 10,000+ active participants (151 plans).
| Measure | Percentile |
|---|---|
| Employer $ per participant | 98th |
| Lower admin cost | 96th |
| Employee saving | 94th |
| Peers that auto-enroll | 69% |
Red flags from the filing
No red flags were reported on this filing's compliance questions.
What to do if you're in this plan
- Genentech put in about $17,667 per active participant, more than the typical peer ($5,480). Contribute at least enough to collect the full match. Skipping it leaves part of your pay on the table.
- The filing shows total dollars, not the match formula. Ask HR for the Summary Plan Description so you know the exact match and vesting schedule.
- Fund expense ratios aren't in the filing. Look them up in your 404(a)(5) fee disclosure and favor low-cost index or target-date funds.
- Changing jobs? You can usually leave the money in the plan, move it to your new employer's plan, or roll it into an IRA. Don't cash out: you'd owe taxes and possibly a 10% penalty.
The raw numbers from the filing
| Employer contributions | $394,022,796 |
| Participant (employee) contributions | $420,880,532 |
| Other contributions (incl. rollovers in) | $45,066,785 |
| Administrative expenses paid from the plan | $1,303,704 |
| Benefits paid out | $1,189,559,981 |
| Net assets, start / end of year | $12.9B / $14.3B |
| Active participants, start / end of year | 22,986 / 21,619 |
| Participants with account balances | 36,215 |
| Auto-enrollment (feature code 2S) | Not reported |
| Auditor | Grant Thornton LLP |
Largest service providers (Schedule C)
| Fidelity Inv Inst Ops Co. Inc. | $913,358 reported compensation |
| Callan Associates Inc. | $274,070 reported compensation |
| Russell Investments | $190,633 reported compensation |
Source: DOL EFAST2 Form 5500 filing, acknowledgment ID 20251007154215NAL0002583779001, received 2025-10-07, EIN 94-2347624, plan #003, plan year 2024-01-01 to 2024-12-31. Verify at efast.dol.gov.
Get notified when Genentech's next filing posts
The most generous employers, the worst red flags, and plain-English 401(k) tips. One email a month.